2025
SJR Q1
JCR Q2 · 3,2
128 matched articles
SCIE
Journal detail
Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers
- Country
- United Arab Emirates · Middle East
- Type
- journal
- ISSN
-
092986731875533X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,735
- Quartile Q1
- H-Index 218
- Cites/doc 3,76
- Docs (3y) 955
- Cites (3y) 3.581
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,2
- 5Y JIF 3,7
- JCI 0,51
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Drug Discovery Q2
- Molecular Medicine Q3
- Organic Chemistry Q1
- Pharmacology Q2
Areas
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,735 | 3,2 | 3,7 | 0,51 | Q3 | 218 |
| 2024 | Q2 | Q2 | 0,778 | 3,5 | 4 | 0,55 | Q3 | 210 |
| 2023 | Q1 | Q2 | 0,759 | 3,5 | 4 | 0,58 | Q3 | 210 |
| 2022 | Q1 | Q2 | 0,776 | 4,1 | 4,6 | 0,62 | Q3 | 210 |
| 2021 | Q1 | Q2 | 0,8 | 4,7 | 5 | 0,66 | Q2 | 210 |
| 2020 | Q1 | Q2 | 0,934 | 4,5 | 4,7 | 0,66 | Q3 | 210 |
| 2019 | Q1 | Q1 | 0,903 | 4,2 | 3,8 | 0,71 | Q2 | 210 |
| 2018 | — | Q1 | — | 3,9 | 3,7 | 0,88 | Q2 | — |
| 2017 | Q2 | Q2 | 1,015 | 3,5 | 3,5 | 1,06 | Q1 | 210 |
| 2016 | Q2 | Q2 | 1,085 | 3,2 | 3,5 | — | — | 210 |
| 2015 | Q2 | Q1 | 0,856 | 3,5 | 3,8 | — | — | 210 |
| 2014 | Q1 | Q1 | 1,282 | 3,9 | 4,1 | — | — | 210 |
| 2013 | Q1 | Q1 | 1,373 | 3,7 | 4,2 | — | — | 210 |
| 2012 | Q1 | Q1 | 1,538 | 4,1 | 4,5 | — | — | 210 |
| 2011 | Q1 | Q1 | 1,699 | 4,9 | 4,8 | — | — | 210 |
| 2010 | Q1 | Q1 | 1,7 | 4,6 | 5 | — | — | 210 |
| 2009 | — | Q1 | — | 4,7 | 5,4 | — | — | — |
| 2008 | — | Q1 | — | 4,8 | 5,3 | — | — | — |
| 2007 | — | Q1 | — | 4,9 | 5,2 | — | — | — |
| 2006 | — | Q1 | — | 5,2 | — | — | — | — |
| 2005 | — | Q1 | — | 4,9 | — | — | — | — |
| 2004 | — | Q1 | — | 4,4 | — | — | — | — |
| 2003 | — | Q1 | — | 4,4 | — | — | — | — |
| 2002 | — | Q1 | — | 5 | — | — | — | — |
| 2001 | — | Q1 | — | 5,8 | — | — | — | — |
| 2000 | — | Q1 | — | 4,9 | — | — | — | — |
| 1999 | — | Q1 | — | 3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,5 | — | — | — | — |
| 1997 | — | Q1 | — | 2,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 185/328 |
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 43/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 156/356 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 136/320 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 35/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 107/352 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 134/313 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 32/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 100/354 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 112/285 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 23/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 94/278 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 122/297 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 22/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 88/279 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 107/295 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 17/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 81/276 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 90/297 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q3 | 14/61 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 53/271 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 91/299 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 12/61 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 55/267 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 103/293 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q1 | 16/59 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 67/261 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 110/290 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/257 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 100/289 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 10/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/255 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 81/290 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 6/59 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 48/255 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 96/291 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 9/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 49/256 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 80/290 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 5/59 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 41/261 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 62/290 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/59 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/261 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 65/286 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/54 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 28/252 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 59/283 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/46 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/237 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 55/275 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/41 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 20/219 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 49/263 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 3/41 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 16/205 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 51/262 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 3/35 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 19/199 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 46/261 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/34 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 20/193 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 54/261 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/36 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/187 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 52/261 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/37 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 20/185 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 48/266 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/35 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 13/188 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 47/308 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 2/36 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 5/186 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 55/310 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 3/35 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 9/181 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 86/295 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 22/175 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 155/295 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 14/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 94/253 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 6/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 30/157 |